IBDEI01Z ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,475,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,475,1,4,0)
 ;;=4^535.50
 ;;^UTILITY(U,$J,358.3,475,1,5,0)
 ;;=5^Gastritis
 ;;^UTILITY(U,$J,358.3,475,2)
 ;;=^270181
 ;;^UTILITY(U,$J,358.3,476,0)
 ;;=682.9^^5^45^26
 ;;^UTILITY(U,$J,358.3,476,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,476,1,4,0)
 ;;=4^682.9
 ;;^UTILITY(U,$J,358.3,476,1,5,0)
 ;;=5^Cellulitis
 ;;^UTILITY(U,$J,358.3,476,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,477,0)
 ;;=691.8^^5^45^34
 ;;^UTILITY(U,$J,358.3,477,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,477,1,4,0)
 ;;=4^691.8
 ;;^UTILITY(U,$J,358.3,477,1,5,0)
 ;;=5^Dermatitis,Atopic
 ;;^UTILITY(U,$J,358.3,477,2)
 ;;=^87342
 ;;^UTILITY(U,$J,358.3,478,0)
 ;;=692.9^^5^45^35
 ;;^UTILITY(U,$J,358.3,478,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,478,1,4,0)
 ;;=4^692.9
 ;;^UTILITY(U,$J,358.3,478,1,5,0)
 ;;=5^Dermatitis,Contact
 ;;^UTILITY(U,$J,358.3,478,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,479,0)
 ;;=692.9^^5^45^42
 ;;^UTILITY(U,$J,358.3,479,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,479,1,4,0)
 ;;=4^692.9
 ;;^UTILITY(U,$J,358.3,479,1,5,0)
 ;;=5^Eczema
 ;;^UTILITY(U,$J,358.3,479,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,480,0)
 ;;=698.9^^5^45^67
 ;;^UTILITY(U,$J,358.3,480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,480,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,480,1,5,0)
 ;;=5^Pruritis
 ;;^UTILITY(U,$J,358.3,480,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,481,0)
 ;;=705.81^^5^45^43
 ;;^UTILITY(U,$J,358.3,481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,481,1,4,0)
 ;;=4^705.81
 ;;^UTILITY(U,$J,358.3,481,1,5,0)
 ;;=5^Eczema,Dyshydrotic
 ;;^UTILITY(U,$J,358.3,481,2)
 ;;=^96545
 ;;^UTILITY(U,$J,358.3,482,0)
 ;;=706.1^^5^45^2
 ;;^UTILITY(U,$J,358.3,482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,482,1,4,0)
 ;;=4^706.1
 ;;^UTILITY(U,$J,358.3,482,1,5,0)
 ;;=5^Acne
 ;;^UTILITY(U,$J,358.3,482,2)
 ;;=^87239
 ;;^UTILITY(U,$J,358.3,483,0)
 ;;=708.3^^5^45^36
 ;;^UTILITY(U,$J,358.3,483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,483,1,4,0)
 ;;=4^708.3
 ;;^UTILITY(U,$J,358.3,483,1,5,0)
 ;;=5^Dermographism
 ;;^UTILITY(U,$J,358.3,483,2)
 ;;=^265291
 ;;^UTILITY(U,$J,358.3,484,0)
 ;;=708.5^^5^45^28
 ;;^UTILITY(U,$J,358.3,484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,484,1,4,0)
 ;;=4^708.5
 ;;^UTILITY(U,$J,358.3,484,1,5,0)
 ;;=5^Cholinergic Urticaria
 ;;^UTILITY(U,$J,358.3,484,2)
 ;;=^265460
 ;;^UTILITY(U,$J,358.3,485,0)
 ;;=708.9^^5^45^77
 ;;^UTILITY(U,$J,358.3,485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,485,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,485,1,5,0)
 ;;=5^Urticaria
 ;;^UTILITY(U,$J,358.3,485,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,486,0)
 ;;=780.61^^5^45^48
 ;;^UTILITY(U,$J,358.3,486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,486,1,4,0)
 ;;=4^780.61
 ;;^UTILITY(U,$J,358.3,486,1,5,0)
 ;;=5^Fever in Oth Diseases
 ;;^UTILITY(U,$J,358.3,486,2)
 ;;=^336667
 ;;^UTILITY(U,$J,358.3,487,0)
 ;;=780.62^^5^45^49
 ;;^UTILITY(U,$J,358.3,487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,487,1,4,0)
 ;;=4^780.62
 ;;^UTILITY(U,$J,358.3,487,1,5,0)
 ;;=5^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,487,2)
 ;;=^336668
 ;;^UTILITY(U,$J,358.3,488,0)
 ;;=780.63^^5^45^50
 ;;^UTILITY(U,$J,358.3,488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,488,1,4,0)
 ;;=4^780.63
 ;;^UTILITY(U,$J,358.3,488,1,5,0)
 ;;=5^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,488,2)
 ;;=^336669
 ;;^UTILITY(U,$J,358.3,489,0)
 ;;=780.64^^5^45^27
 ;;^UTILITY(U,$J,358.3,489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,489,1,4,0)
 ;;=4^780.64
 ;;^UTILITY(U,$J,358.3,489,1,5,0)
 ;;=5^Chills w/o Fever
 ;;^UTILITY(U,$J,358.3,489,2)
 ;;=^336670
